Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
Jedd D. Wolchok, M.D., Ph.D. - Cancer Research Institute
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => 821E72D22569130030B7FD9050FE0039.app30110b [routing_id] => 00000000.app30110b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30110b?NONCE_TOKEN=63917EE006BFA8DF1BAF0571D9D8499E [token] => RFNM3PD9DC_fCipzceS1T-PNXMRc3KcoldGb4PcTY5gkqqljoYnTmmAREIEjqL8pcphVBit04Ms-eahsWPlF-7eGgV82uiZ-RdazS7Q ) ) test
Scientific Advisory Council

Directors

Jedd D. Wolchok, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

New York, NY

Dr. Jedd D. Wolchok is the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation; Chief, Immuno-Oncology Service, Human Oncology and Pathogenesis Program; director, Parker Institute for Cancer Immunotherapy; and associate director, the Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center.

Dr. Wolchok has been at the forefront of cancer immunotherapy and is renowned for leading the clinical trials that led to the first FDA-approved checkpoint inhibitor immunotherapy, the anti-CTLA-4 antibody ipilimumab. He continues to lead clinical trials aimed at expanding immunotherapy’s benefits to more patients. He also conducts research that focuses on the GITR and OX40 pathways, as well as how some immune cells, known as myeloid-derived suppressor cells, influence anti-tumor immune responses.

In addition to his role as an associate director of CRI’s Scientific Advisory Council, Dr. Wolchok serves on the CLIP Grant Review Committee and is also a member of CRI’s Clinical Leadership Committee.

This site is registered on wpml.org as a development site.